Omar Farooq Khan, Mohammed Ali Alvi, Marina Salluzzi, Ronald Bridges, Alexander S. Watson, Felipe Soares Torres, Natasha B. Leighl, John Riskas, Shahid Abbas Haider, Vignesh Sivan, Oleksandra Samorodova, Thomas Jay Hennessy, Duoaud Shah, Melissa Curtis, Felix Baldauf-Lenschen. "Association between depth of IPRO-α response and overall survival (OS) in patients with advanced non–small cell lung cancer (aNSCLC) treated with first-line (1L) pembrolizumab monotherapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e20521